These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8889041)

  • 1. Transport mechanism of pirarubicin in human mononuclear cells.
    Nagasawa K; Tsumura A; Nomiyama M; Ohnishi N; Yokoyama T
    Biol Pharm Bull; 1996 Sep; 19(9):1203-9. PubMed ID: 8889041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of daunorubicin and doxorubicin in HL60 and its resistant cells and comparison with those of pirarubicin.
    Nagasawa K; Natazuka T; Nomiyama M; Ohnishi N; Yokoyama T
    Biol Pharm Bull; 1996 Jan; 19(1):100-5. PubMed ID: 8820920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
    Nagasawa K; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
    Biol Pharm Bull; 1996 Jul; 19(7):971-6. PubMed ID: 8839972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport mechanisms of idarubicin, an anthracycline derivative, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs.
    Nagasawa K; Ohnishi N; Yokoyama T
    Jpn J Cancer Res; 1997 Aug; 88(8):750-9. PubMed ID: 9330607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
    Nagasawa K; Natazuka T; Chihara K; Kitazawa F; Tsumura A; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
    Cancer Chemother Pharmacol; 1996; 37(4):297-304. PubMed ID: 8548874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possibility of contribution of nucleoside transport systems to pirarubicin uptake by HL60 cells but not mononuclear cells.
    Nagasawa K; Ohnishi N; Yokoyama T
    Jpn J Cancer Res; 1998 Jun; 89(6):673-80. PubMed ID: 9703366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport mechanism of anthracycline derivatives in rat polymorphonuclear leukocytes: uptake of pirarubicin, daunorubicin and doxorubicin.
    Nagasawa K; Nomiyama M; Ohnishi N; Yokoyama T; Iwakawa S; Okumura K
    Biol Pharm Bull; 1994 Sep; 17(9):1305-8. PubMed ID: 7841960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the nucleoside transport system to doxorubicin transport in HL60 cells but not in mononuclear cells.
    Nagasawa K; Fumihara T; Ohnishi N; Yokoyama T
    Jpn J Cancer Res; 1999 Jul; 90(7):781-7. PubMed ID: 10470292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of the anthracycline pirarubicin into mouse M5076 ovarian sarcoma cells via a sodium-dependent nucleoside transport system.
    Nagai K; Nagasawa K; Fujimoto S
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):222-30. PubMed ID: 15526202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
    Inaba M; Kobayashi H; Sakurai Y; Johnson RK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport mechanism of anthracycline derivatives in rat polymorphonuclear leukocytes: uptake and efflux of pirarubicin.
    Nagasawa K; Nomiyama M; Ohnishi N; Yokoyama T; Iwakawa S; Okumura K
    Biol Pharm Bull; 1994 May; 17(5):696-700. PubMed ID: 7920436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells.
    Versantvoort CH; Broxterman HJ; Lankelma J; Feller N; Pinedo HM
    Biochem Pharmacol; 1994 Sep; 48(6):1129-36. PubMed ID: 7945406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirarubicin is taken up by a uridine-transportable sodium-dependent concentrative nucleoside transporter in Ehrlich ascites carcinoma cells.
    Nagai K; Nagasawa K; Ishimoto A; Fujimoto S
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):512-8. PubMed ID: 12679883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the binding of anthracycline derivatives to purified DNA and to cell nuclei.
    Frezard F; Garnier-Suillerot A
    Biochim Biophys Acta; 1990 Nov; 1036(2):121-7. PubMed ID: 2223830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
    Krishan A; Sauerteig A; Gordon K; Swinkin C
    Cancer Res; 1986 Apr; 46(4 Pt 1):1768-73. PubMed ID: 3948163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
    Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy.
    Gervasoni JE; Fields SZ; Krishna S; Baker MA; Rosado M; Thuraisamy K; Hindenburg AA; Taub RN
    Cancer Res; 1991 Sep; 51(18):4955-63. PubMed ID: 1680024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport mechanism of anthracycline derivatives in rat polymorphonuclear leukocytes: effect of sodium fluoride on pirarubicin uptake.
    Nagasawa K; Tsumura A; Kitazawa F; Nomiyama M; Ohnishi N; Yokoyama T
    Biol Pharm Bull; 1995 Feb; 18(2):368-71. PubMed ID: 7742815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.